F.D.A. Revokes Approval of Avastin as Breast Cancer Drug

F.D.A. Revokes Approval of Avastin as Breast Cancer Drug

The Food and Drug Administration announced Friday that it was revoking its approval of the drug Avastin for breast cancer after concluding that it "has not been shown to be safe and effective for that use."

“After reviewing the available studies,” she continued, “it is clear that women who take Avastin for metastatic breast cancer risk potentially life-threatening side effects without proof that the use of Avastin will provide a benefit, in terms of delay in tumor growth, that would justify those risks. Nor is there evidence that use of Avastin will help them live longer or improve their quality of life.”

Read more:

http://www.nytimes.com/2011/11/19/business/fda-revokes-approval-of-avastin-as...

See also:

"Chemo Does Not Cure: Often It Inflicts Damage and Spreads Cancer"